These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38316854)

  • 1. A probabilistic computation framework to estimate the dawn phenomenon in type 2 diabetes using continuous glucose monitoring.
    Barua S; Glantz N; Larez A; Bevier W; Sabharwal A; Kerr D
    Sci Rep; 2024 Feb; 14(1):2915. PubMed ID: 38316854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dawn phenomenon in type 2 diabetes: how to assess it in clinical practice?
    Monnier L; Colette C; Dejager S; Owens D
    Diabetes Metab; 2015 Apr; 41(2):132-7. PubMed ID: 25457475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dawn phenomenon across the glycemic continuum: Implications for defining dysglycemia.
    Li C; Ma X; Yin J; Mo Y; Zhang L; Lu J; Lu W; Bao Y; Vigersky RA; Zhou J; Jia W
    Diabetes Res Clin Pract; 2020 Aug; 166():108308. PubMed ID: 32650035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of the dawn phenomenon to the fasting and postbreakfast hyperglycemia in type 1 diabetes treated with once-nightly insulin glargine.
    King AB; Clark D; Wolfe GS
    Endocr Pract; 2012; 18(4):558-62. PubMed ID: 22548951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Exercise on Blood Glucose and Glycemic Variability in Type 2 Diabetic Patients with Dawn Phenomenon.
    Zheng X; Qi Y; Bi L; Shi W; Zhang Y; Zhao D; Hu S; Li M; Li Q
    Biomed Res Int; 2020; 2020():6408724. PubMed ID: 32149118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of glycemia in insulin resistance in youth with type 1 and type 2 diabetes.
    Chan CL; Pyle L; Morehead R; Baumgartner A; Cree-Green M; Nadeau KJ
    Pediatr Diabetes; 2017 Sep; 18(6):470-477. PubMed ID: 27503277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dawn phenomenon in type 2 diabetes: its association with glucose excursions and changes after oral glucose-lowering drugs.
    Wang JS; Lee IT; Lee WJ; Lin SD; Su SL; Tu ST; Lin SY; Sheu WH
    Ther Adv Chronic Dis; 2021; 12():20406223211033674. PubMed ID: 34394904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of the dawn phenomenon in type 2 diabetes: implications for diabetes therapy.
    Carroll MF; Hardy KJ; Burge MR; Schade DS
    Diabetes Technol Ther; 2002; 4(5):595-605. PubMed ID: 12450440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The northeast glucose drift: Stratification of post-breakfast dysglycemia among predominantly Hispanic/Latino adults at-risk or with type 2 diabetes.
    Barua S; Sabharwal A; Glantz N; Conneely C; Larez A; Bevier W; Kerr D
    EClinicalMedicine; 2022 Jan; 43():101241. PubMed ID: 34988413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nocturnal blood glucose control in type I diabetes mellitus.
    Bolli GB; Perriello G; Fanelli CG; De Feo P
    Diabetes Care; 1993 Dec; 16 Suppl 3():71-89. PubMed ID: 8299480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrinological evaluation of dawn phenomenon in patients with diabetes and comparison of insulin glargine U-100 biosimilar (Insulin Glargine BS Injection "Lilly") and glargine U-300 (Lantus XR): a randomized controlled study.
    Hasebe M; Satoh S; Ito K; Tamura H; Terauchi Y
    Endocr J; 2023 Aug; 70(8):777-786. PubMed ID: 37164694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Interventional Evidence.
    Seidu S; Kunutsor SK; Ajjan RA; Choudhary P
    Diabetes Care; 2024 Jan; 47(1):169-179. PubMed ID: 38117991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysglycemia in adults at risk for or living with non-insulin treated type 2 diabetes: Insights from continuous glucose monitoring.
    Barua S; Sabharwal A; Glantz N; Conneely C; Larez A; Bevier W; Kerr D
    EClinicalMedicine; 2021 May; 35():100853. PubMed ID: 33997745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and Prediabetes Classification Using Glycemic Variability Indices From Continuous Glucose Monitoring Data.
    Acciaroli G; Sparacino G; Hakaste L; Facchinetti A; Di Nunzio GM; Palombit A; Tuomi T; Gabriel R; Aranda J; Vega S; Cobelli C
    J Diabetes Sci Technol; 2018 Jan; 12(1):105-113. PubMed ID: 28569077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose variability and low bone turnover in people with type 2 diabetes.
    Starup-Linde J; Lykkeboe S; Handberg A; Vestergaard P; Høyem P; Fleischer J; Hansen TK; Poulsen PL; Laugesen E
    Bone; 2021 Dec; 153():116159. PubMed ID: 34461287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous glucose monitoring systems for type 1 diabetes mellitus.
    Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study.
    Gilbert TR; Noar A; Blalock O; Polonsky WH
    Diabetes Technol Ther; 2021 Mar; 23(S1):S35-S39. PubMed ID: 33470882
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes.
    Chan CL
    Curr Diab Rep; 2017 Sep; 17(9):66. PubMed ID: 28726154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dawn phenomenon revisited: implications for diabetes therapy.
    Carroll MF; Schade DS
    Endocr Pract; 2005; 11(1):55-64. PubMed ID: 16033737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.